News Conference News TCT 2025 Ultrathin-Strut DES Performs Well vs Xience in Diabetic Patients: TUXEDO-2 Todd Neale November 03, 2025
News Daily News DCB in Diabetes Show Promising Long-term Outcomes: BASKET-SMALL 2 L.A. McKeown August 16, 2021
News Daily News Registry Supports Paclitaxel DCBs in CLI Patients to 2 Years L.A. McKeown September 17, 2020
News Conference News ISET 2019 Eluvia Sustains Lead Over Zilver PTX in Patients With Diabetes: IMPERIAL Subanalysis Caitlin E. Cox January 30, 2019
News Daily News Everolimus Stent Better Than Paclitaxel Stent in Diabetic Patients, Even Those Requiring Insulin: TUXEDO Analysis Michael O'Riordan April 25, 2016
News Daily News Drug-Eluting Balloons Reduce Restenosis, TLR in Diabetic Patients with CLI Yael L. Maxwell February 26, 2014
News Daily News Drug-Eluting Balloons Lower TLR in Diabetics with Critical Limb Ischemia Jason Kahn July 05, 2013
News Daily News No Apparent Advantage for Everolimus vs. Paclitaxel Stents in Diabetic Patients L.A. McKeown August 19, 2011
News Daily News ESSENCE-DIABETES Published: Xience, Cypher Equally Equipped to Treat Diabetics Caitlin E. Cox August 03, 2011
News Daily News HORIZONS-AMI: Bivalirudin Reduces Cardiac Death in Diabetics Jason Kahn July 18, 2011
News Daily News Studies Support DES Use in Diabetics, But Results Vary by Device Caitlin E. Cox March 08, 2011